Patents by Inventor Cameron W. Brennan

Cameron W. Brennan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8999633
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human pancreatic adenocarcinoma. A variety of chromosomal regions (MCRs) and markers in the MCRs, are provided that are correlated with cancer. In particular, chromosomal regions and markers in the MCR 50.06-62.89 Mb of human chromosome 19, are provided, wherein alterations in the copy number of the MCR and/or alterations in the amount, structure, and/or activity of one or more of the markers in the MCR is correlated with the presence of pancreatic adenocarcinoma.
    Type: Grant
    Filed: May 27, 2005
    Date of Patent: April 7, 2015
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Lynda Chin, Cameron W. Brennan, Ronald A. DePinho, Andrew J. Aguirre
  • Patent number: 8211634
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.
    Type: Grant
    Filed: February 13, 2007
    Date of Patent: July 3, 2012
    Assignees: Dana-Farber Cancer Institute, Inc., Board of Trustees of the University of Arkansas
    Inventors: Ronald A. DePinho, Kenneth C. Anderson, Ruben D. Carrasco, Giovanni Tonon, Cameron W. Brennan, John D. Shaughnessy, Jr., Lynda Chin
  • Publication number: 20090297536
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human cancer. A variety of chromosomal regions (MCRs) and markers corresponding thereto, are provided, wherein alterations in the copy number of one or more of the MCRs and/or alterations in the amount, structure, and/or activity of one or more of the markers is correlated with the presence of cancer.
    Type: Application
    Filed: May 27, 2005
    Publication date: December 3, 2009
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Lynda Chin, Cameron W. Brennan, Ronald A. DePinho, Andrew J. Aguirre